FENTORA
Total Payments
$19,378
Transactions
2
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $9,717 | 1 | 1 |
| 2017 | $9,661 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,717 | 1 | 50.1% |
| Unspecified | $9,661 | 1 | 49.9% |
Payments by Type
General
$9,717
1 transactions
Research
$9,661
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Preliminary Study of Prophylactic Fentanyl Buccal Tablet (FBT) for Exercise-Induced Breathrough Dyspnea | Teva Pharmaceuticals USA, Inc. | $9,661 | 0 |
Top Doctors Receiving Payments for FENTORA
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Hospice and Palliative Medicine | Tampa, FL | $9,717 | 1 |
| Unknown | — | Houston, TX | $9,661 | 1 |
Ad
Manufacturing Companies
- Teva Pharmaceuticals USA, Inc. $19,378
Product Information
- Type Drug
- Total Payments $19,378
- Total Doctors 1
- Transactions 2
About FENTORA
FENTORA is a drug associated with $19,378 in payments to 1 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is Teva Pharmaceuticals USA, Inc..
Payment data is available from 2017 to 2019. In 2019, $9,717 was paid across 1 transactions to 1 doctors.
The most common payment nature for FENTORA is "Consulting Fee" ($9,717, 50.1% of total).
FENTORA is associated with 1 research study, including "A Preliminary Study of Prophylactic Fentanyl Buccal Tablet (FBT) for Exercise-Induced Breathrough Dyspnea" ($9,661).